Now Long On Valeant, Andrew Left Backtracks On 'Uninvestible' Comment
May 17, 2016 at 16:09 PM EDT
Andrew Left and his research firm, Citron Research, previously trashed Valeant Pharmaceuticals Intl Inc (NYSE: VRX) business, calling ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.